Nutanix (NASDAQ:NTNX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the sixteen brokerages that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $91.00.
A number of equities research analysts recently commented on the company. Needham & Company LLC reissued a “buy” rating and issued a $92.00 price target on shares of Nutanix in a research report on Thursday, May 29th. Susquehanna increased their price target on Nutanix from $90.00 to $95.00 and gave the company a “positive” rating in a research report on Thursday, May 29th. Morgan Stanley reissued an “overweight” rating and issued a $90.00 price target (up from $75.00) on shares of Nutanix in a research report on Tuesday, May 20th. The Goldman Sachs Group initiated coverage on Nutanix in a research note on Tuesday, July 15th. They issued a “buy” rating and a $95.00 price objective for the company. Finally, Wall Street Zen downgraded Nutanix from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 30th.
Insider Transactions at Nutanix
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. CWM LLC boosted its stake in Nutanix by 25.5% in the 2nd quarter. CWM LLC now owns 87,937 shares of the technology company’s stock worth $6,722,000 after purchasing an additional 17,888 shares during the period. OFI Invest Asset Management bought a new position in Nutanix in the 2nd quarter worth about $113,000. Vanguard Personalized Indexing Management LLC boosted its stake in Nutanix by 4.3% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 16,874 shares of the technology company’s stock worth $1,290,000 after purchasing an additional 692 shares during the period. Concurrent Investment Advisors LLC boosted its stake in Nutanix by 8.2% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 4,505 shares of the technology company’s stock worth $344,000 after purchasing an additional 342 shares during the period. Finally, waypoint wealth counsel bought a new position in Nutanix in the 2nd quarter worth about $299,000. Institutional investors own 85.25% of the company’s stock.
Nutanix Trading Up 0.9%
NASDAQ NTNX opened at $74.69 on Friday. The firm has a market capitalization of $20.02 billion, a P/E ratio of 152.43, a PEG ratio of 6.90 and a beta of 0.67. The business has a fifty day simple moving average of $75.75 and a 200 day simple moving average of $71.25. Nutanix has a 12 month low of $43.35 and a 12 month high of $83.36.
Nutanix (NASDAQ:NTNX – Get Free Report) last released its quarterly earnings results on Wednesday, June 4th. The technology company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.04. The business had revenue of $638.98 million during the quarter, compared to analyst estimates of $626.12 million. Nutanix had a negative return on equity of 21.32% and a net margin of 0.97%. Nutanix’s quarterly revenue was up 21.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.28 EPS. As a group, sell-side analysts predict that Nutanix will post 0.31 EPS for the current fiscal year.
Nutanix Company Profile
Nutanix, Inc engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure.
Further Reading
- Five stocks we like better than Nutanix
- What is Short Interest? How to Use It
- Crypto Skeptics Can Still Win Big With These Risk-Limiting ETFs
- 3 Monster Growth Stocks to Buy Now
- 3 Discounted Steel Stocks You Can DCA Into Today
- 3 Healthcare Dividend Stocks to Buy
- Could Baker Hughes Be an Unlikely Winner in Drone Defense Boom?
Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.